Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Minutes of the TME Pharma Annual General Meeting
Minutes of the TME Pharma Annual General Meeting Berlin, Germany, June 17, 2026, 6:30 p.m. CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for…
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?
iShares U.S. Pharmaceuticals ETF (IHE 0.86%) offers a more stable, dividend-focused path into healthcare compared to the high-volatility, equal-weighted growth profile of the State Street SPDR S&P Biotech ETF (XBI +2.91%). Both funds launched in…
Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum
Clinical-stage biotech Nuvation Bio, focused on oncology therapeutics, reported a recent insider buy amid a year of sharp share price gains. On June 9, 2026, Director Robert Mashal reported the acquisition of 25,000 shares of Nuvation Bio (NUVB…
The Healthcare M&A Wave
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here. Pharmaceutical M&A reached $65 billion in the first quarter, its highest number since 2020…
Six charts show challenges facing Swiss pharmaceutical industry
In 2023, nearly 350 companies were active in the pharmaceutical industry in Switzerland, according to the Federal Statistical OfficeExternal link. These included global pharma heavyweights under Swiss control, such as Novartis, Roche and Sandoz.
How a decade of pharma digitalization drove Nordic's $8.9 bn sale of Clario to Thermo Scientific
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
BridgeBio Pharma, Inc. $BBIO Shares Sold by Granahan Investment Management LLC
Granahan Investment Management LLC lowered its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 36.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm…
U.S. Futures Edge Up, European Stocks Mixed
U.S. futures for the S&P 500 were up 0.3% and futures for the Dow Jones Industrial Average climbed 0.1%. Changes in futures do not necessarily predict movements after the opening bell. In Europe, the Stoxx Europe 600 gained 0.1% in morning trading.
Dorsey Asset Management LLC Trims Stake in Royalty Pharma PLC $RPRX
Dorsey Asset Management LLC cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 3.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The…
Ascendis Pharma A/S $ASND Shares Purchased by Fred Alger Management LLC
Fred Alger Management LLC increased its position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 106.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 352,109…
Delta Global Management LP Acquires Shares of 44,314 Royalty Pharma PLC $RPRX
Delta Global Management LP acquired a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 44,314 shares of the…
Artisan Partners Limited Partnership Has $687.89 Million Stock Position in Ascendis Pharma A/S $ASND
Artisan Partners Limited Partnership trimmed its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 13.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the…
ExodusPoint Capital Management LP Has $17.68 Million Stock Holdings in Ascendis Pharma A/S $ASND
ExodusPoint Capital Management LP increased its position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 235.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm…
ClearBridge Appreciation Fund Q1 2026 Commentary (SHAPX)
The ClearBridge Appreciation Fund performed better than the benchmark S&P 500 Index in the first quarter of 2026, with positive contributions from five of 11 sectors. ASML share performance was primarily fueled by record-breaking orders for AI…
Receive a Daily briefing on Pharma Industry News
Get Started